Evidence map›Paper›PMID 41674277›Full record

ReviewInternational journal of immunopathology and pharmacology

Impact of hepatitis C virus on oral health: Clinical lesions, immunopathology, and dental management: A narrative review.

Mario Alberto Alarcón-Sánchez, Valeria Henao-Díaz, Lilibeth-Stephania Escoto-Vasquez, Melissa Martínez-Nieto, Gustavo Eder González-Alvarez, Armen A Muradyan, Artak Heboyan, Sarah Monserrat Lomelí-Martínez

Abstract readReview
In one paragraph

Review in International journal of immunopathology and pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mario Alberto Alarcón-SánchezMolecular Biology in Medicine Program, University Center of Health Sciences, University of Guadalajara (CUCS-UdeG), Guadalajara, Jalisco, Mexico.ORCID 0000-0001-6727-7969
Valeria Henao-DíazCatholic University of Manizales, Manizales, Caldas, Colombia.
Lilibeth-Stephania Escoto-VasquezDepartment of Oral Medicine and Pathology, Postgraduate Division, Dental School, National Autonomous University of Mexico, Mexico City, Jalisco, Mexico.
Melissa Martínez-NietoDepartment of Integral Dental Clinics, University Center of Health Sciences, University of Guadalajara (CUCS-UdeG), Guadalajara, Jalisco, México.ORCID 0009-0007-1843-384X
Gustavo Eder González-AlvarezDepartment of Medical and Life Sciences, La Ciénega University Center, University of Guadalajara (CUCIENEGA-UdeG), Ocotlán, Jalisco, Mexico.ORCID 0009-0007-6112-8779
Armen A MuradyanAdministrative Department, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
Artak HeboyanDepartment of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.ORCID 0000-0001-8329-3205
Sarah Monserrat Lomelí-MartínezDepartment of Medical and Life Sciences, La Ciénega University Center, University of Guadalajara (CUCIENEGA-UdeG), Ocotlán, Jalisco, Mexico.ORCID 0000-0002-0569-1387

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis C virus (HCV) infection is a major global public health problem. Although it has traditionally been linked to liver damage, several studies have demonstrated its extrahepatic impact, specifically in the oral cavity. Oral manifestations can be considered early signs of infection or contribute to clinical progression. This narrative review aims to describe the oral alterations associated with HCV, integrating the pathophysiological mechanisms and clinical implications for dental management. The most prevalent manifestations include periodontal disease, oral lichen planus, Sjögren's syndrome-like sialadenitis, and squamous cell carcinoma of the oral cavity. Recent findings suggest that HCV triggers dysbiosis of the oral microbiome, promotes exacerbated immune responses with overproduction of pro-inflammatory cytokines, and disrupts the homeostatic environment, thereby promoting the progression of inflammatory and neoplastic diseases. In addition, viral RNA has been identified in saliva and gingival crevicular fluid, which could be considered a non-parenteral route of transmission, particularly important in dental interventions. In parallel, direct-acting antiviral therapy, in addition to achieving virus elimination, could also partially correct immunological and microbial disruptions in the cavity, with favorable clinical responses. Understanding these oral alterations can guide dentists in early detection and improve systemic outcomes.

Indexed as

HepacivirusHepatitis CMouth DiseasesOral HealthAntiviral AgentsHumansLichen Planus, OralMouth NeoplasmsPeriodontal DiseasesAntiviral Agentshepatitis Coral dysbiosisoral lichen planusoral manifestationsperiodontal diseaseSjögren’s-like sialadenitissquamous cell carcinoma of the oral cavity

Identifiers

PMID41674277
PMCPMC12901906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.